Benfovitamax Tablets

Adult dose

For those aged 12 and older: take 1 tablet once daily.

This medication should not be taken by patients with hypercalcemia or sarcoidosis, which is an unknown cause systemic inflammatory disease, and individuals with kidney disease. Additionally, those who are allergic to this medication or its components, infants under 12 months of age, patients with kidney stones, severe renal failure, or are allergic to soybean oil, soy, or peanuts should also avoid this medication. During the use of this medication, it is advisable not to combine it with phosphates, calcium salts, oral tetracycline antibiotics, antacids, or medications such as levodopa. Patients receiving treatment from a doctor or those with hyperoxaluria, pregnant or lactating women, premature infants, infants, gastrointestinal diseases, heart or circulatory disorders, kidney disorders, hypoproteinemia, gout, or history of kidney stones should consult a specialist before taking this medication. If any abnormal symptoms such as nausea, vomiting, diarrhea, skin rash, loss of appetite, abdominal distension, irregular heartbeats, or central nervous system dysfunction occur during use, consumption should be stopped immediately and a specialist should be consulted. Additionally, this medication may lead to changes in menstrual cycles or prolonged bleeding and may increase the risk of thrombosis when taken with oral contraceptives, so caution is needed. Long-term high-dose use can lead to tolerance, and there may be neurological disorders or hematological adverse reactions when taken with certain vitamins, so it should be taken under expert guidance. Excessive dosing may cause gastrointestinal disturbances, hypernatremia, congestive heart failure, and edema, and caution should be exercised when taken with certain diuretics due to the risk of hyperkalemia. This medication should be taken according to the prescribed usage and dosage, as it may affect urine test results and can change urine color to yellow. It is advisable to avoid consuming tannin-containing teas such as green tea or black tea before and after taking this medication. Patients at risk for fat overload should monitor plasma lipid levels and adjust dosage accordingly, and when administered simultaneously with other lipid-lowering agents, the total lipid content should be considered for dose adjustment. Finally, this medication should be stored out of the reach of children, protected from direct sunlight, in a cool, dry, and airtight location, and should not be transferred to other containers to maintain its quality.

Serious side effects

Cardiac arrest (premature contractions), pulmonary edema (swelling).

Mild side effects

Nausea, vomiting, diarrhea, discomfort in the upper abdomen, constipation, rash, redness (erythema), loose stools, loss of appetite, abdominal distention, red spots, cardiac arrest (premature contractions), central nervous system dysfunction, dermatitis, sweating with bad odor, hair loss, restlessness, gastrointestinal disturbances, digestive disorders, upper abdominal pain, hypotension, pulmonary edema (swelling), menstrual cycle may be early or heavier than usual, prolonged bleeding may occur, and sensory disturbances.

Drug interactions

This medication should not be taken with phosphates, calcium salts, oral tetracycline drugs, antacids, or levodopa. Additionally, when taking together with anti-aldosterone agents, trimethoprim, oral contraceptives containing estrogens, consultation with a doctor or pharmacist is required.

Food interactions

This medication should be avoided when taken with tannin-containing beverages such as green tea or black tea.

This medication should be stored in a tightly sealed container to prevent air entry, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage maintains the medication's efficacy and prevents deterioration.

Appearance

Pale yellow oblong film-coated tablet

Package unit

Bottle - 60 tablets/bottle, Box - 120 tablets (60 tablets/bottle x 2)